Ventyx Biosciences, Inc.
VTYXNASDAQHealthcare
$14.00
+$0.00(+0.00%)
Market Cap$1.0B
P/E Ratio—
52W High$25
52W Low$0.783
Ventyx Biosciences, Inc. (VTYX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
VTYX · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 6, 2025EPS Actual
-$0.32
Est. -$0.45 · +28.9%
Revenue
—
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 6, 2025
After Market Close
▲ Beat EPS🔥 4-Quarter EPS Beat Streak
VTYX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2026 | Mar 5, 2026 | -$0.39 | — | — | — | — | — |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.45 | -$0.32 | +28.9% | — | — | — |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.45 | -$0.38 | +15.6% | — | — | — |
| ▲ Q2 FY2025 | May 8, 2025 | -$0.48 | -$0.39 | +18.8% | — | — | — |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.54 | -$0.41 | +24.1% | — | — | — |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.48 | -$0.50 | -4.2% | — | — | — |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$0.57 | -$0.45 | +21.1% | — | — | — |
| ▲ Q2 FY2024 | May 9, 2024 | -$0.67 | -$0.62 | +7.5% | — | — | — |
Q1 FY2026
Mar 5, 2026
EPS Actual
—
EPS Est.
-$0.39
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
-$0.32
EPS Est.
-$0.45
EPS Surpr.
+28.9%
Revenue
—
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.38
EPS Est.
-$0.45
EPS Surpr.
+15.6%
Revenue
—
Q2 FY2025
May 8, 2025Beat
EPS Actual
-$0.39
EPS Est.
-$0.48
EPS Surpr.
+18.8%
Revenue
—
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.41
EPS Est.
-$0.54
EPS Surpr.
+24.1%
Revenue
—
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.50
EPS Est.
-$0.48
EPS Surpr.
-4.2%
Revenue
—
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$0.45
EPS Est.
-$0.57
EPS Surpr.
+21.1%
Revenue
—
Q2 FY2024
May 9, 2024Beat
EPS Actual
-$0.62
EPS Est.
-$0.67
EPS Surpr.
+7.5%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q3 FY2026 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q2 FY2026 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Q1 FY2026 | $-0.52 | $-0.46 | $-0.37 | 2 |
| Q4 FY2025 | $-0.46 | $-0.39 | $-0.30 | 4 |
| Q3 FY2025 | $-0.54 | $-0.45 | $-0.40 | 5 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Nov 6, 2025 | +28.9% | $9.00 | $9.26 | +2.89% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +15.6% | $2.53 | $2.36 | -6.72% |
| ▲ Q2 FY2025 | May 8, 2025 | +18.8% | $1.21 | $1.17 | -3.31% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +24.1% | $1.53 | $1.45 | -5.23% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -4.2% | $2.33 | $2.24 | -3.86% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +21.1% | $1.96 | $1.98 | +1.02% |
| ▲ Q2 FY2024 | May 9, 2024 | +7.5% | $4.44 | $4.48 | +0.90% |
| ▼ Q1 FY2024 | Feb 27, 2024 | -1.3% | $5.86 | $6.05 | +3.24% |
Q4 FY2025+2.89%
Report Date
Nov 6, 2025
EPS Beat/Miss
+28.9%
Price Before
$9.00
Price After
$9.26
Q3 FY2025-6.72%
Report Date
Aug 7, 2025
EPS Beat/Miss
+15.6%
Price Before
$2.53
Price After
$2.36
Q2 FY2025-3.31%
Report Date
May 8, 2025
EPS Beat/Miss
+18.8%
Price Before
$1.21
Price After
$1.17
Q1 FY2025-5.23%
Report Date
Feb 27, 2025
EPS Beat/Miss
+24.1%
Price Before
$1.53
Price After
$1.45
Q4 FY2024-3.86%
Report Date
Nov 7, 2024
EPS Beat/Miss
-4.2%
Price Before
$2.33
Price After
$2.24
Q3 FY2024+1.02%
Report Date
Aug 8, 2024
EPS Beat/Miss
+21.1%
Price Before
$1.96
Price After
$1.98
Q2 FY2024+0.90%
Report Date
May 9, 2024
EPS Beat/Miss
+7.5%
Price Before
$4.44
Price After
$4.48
Q1 FY2024+3.24%
Report Date
Feb 27, 2024
EPS Beat/Miss
-1.3%
Price Before
$5.86
Price After
$6.05
Avg Beat Reaction-1.74%
Avg Miss Reaction-0.31%
Beat Rate6 / 8 quarters
Largest Move-6.72% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: VTYX ends December
Ventyx Biosciences, Inc. (VTYX) most recently reported earnings on November 6, 2025 for Q4 FY2025, posting EPS of $-0.32 — beating the analyst consensus of $-0.45 by +28.9%. VTYX has beaten EPS estimates for 4 consecutive quarters. The next VTYX earnings date is expected around September 1, 2026.
Each quarter, investors track VTYX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VTYX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
VTYX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
VTYX earnings · 5 questionsVentyx Biosciences, Inc.'s next earnings report is expected around September 1, 2026. VTYX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VTYX historically reports after market close (AMC).
VTYX earnings datewhen is VTYX earningsVTYX next earnings datewhen does VTYX report earningsVTYX earnings calendar
▸ Source: FMP · Ventyx Biosciences, Inc. SEC filings · US GAAP · Ventyx Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026